Last quarter (Q4 2023), ANI Pharmaceuticals's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, ANI Pharmaceuticals's net income was $―. See ANI Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 355.16M	$ 486.82M	$ 316.38M	$ 216.14M	$ 208.47M	$ 206.55M
Cost of Revenue	$ 128.09M	$ 181.51M	$ 138.78M	$ 100.61M	$ 87.16M	$ 63.15M
Gross Profit	$ 227.07M	$ 305.30M	$ 177.60M	$ 115.53M	$ 121.32M	$ 143.39M
Operating Expense	$ 183.74M	$ 255.93M	$ 203.33M	$ 143.69M	$ 114.36M	$ 126.97M
Operating Income	$ 43.33M	$ 49.37M	$ -25.73M	$ -28.17M	$ 6.96M	$ 16.43M
Net Non Operating Interest Income Expense	$ -21.25M	$ -26.94M	$ -28.05M	$ 11.92M	$ -9.45M	$ -12.97M
Other Income Expense	$ 2.03M	$ 1.43M	$ 3.20M	$ -15.97M	$ -940.00K	$ -303.00K
Pretax Income	$ 18.93M	$ 19.87M	$ -62.66M	$ -56.06M	$ -25.96M	$ 3.16M
Tax Provision	$ 1.30M	$ 1.09M	$ -14.77M	$ -13.46M	$ -3.41M	$ -2.94M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 16.41M	$ 17.15M	$ -49.52M	$ -42.79M	$ -22.55M	$ 6.00M
Basic EPS	$ 0.82	$ 0.86	$ -3.05	$ -3.40	$ -1.88	$ 0.51
Diluted EPS	$ 0.80	$ 0.85	$ -3.05	$ -3.40	$ -1.88	$ 0.50
Basic Average Shares	$ 52.96M	$ 18.00M	$ 16.26M	$ 12.60M	$ 11.96M	$ 11.84M
Diluted Average Shares	$ 53.51M	$ 18.19M	$ 16.26M	$ 12.60M	$ 11.96M	$ 12.04M
Dividend Per Share	-	-	-	$ 7.60	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	$ 3.50	$ 5.06
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 311.83M	-	$ 342.12M	$ -244.31M	$ 201.52M	$ 190.12M
Net Income From Continuing And Discontinued Operation	$ 16.41M	$ 17.15M	$ -47.90M	$ -42.60M	$ -22.55M	$ 6.09M
Normalized Income	$ 15.44M	$ 15.74M	$ -71.64M	$ -57.89M	$ -22.16M	$ 6.15M
Interest Expense	-	-	-	-	$ 9.45M	$ 12.97M
EBIT	$ 40.17M	$ 46.81M	$ -34.61M	$ -44.14M	$ -16.51M	$ 16.12M
EBITDA	$ 84.77M	$ 106.60M	$ 25.04M	$ 3.12M	$ 28.13M	$ 60.73M

Currency in USD

ANI Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing